We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBS icon
526
UBS Group
UBS
$173B
$1.64M 0.03%
80,997
-9,662
-11% -$194K
MDC
527
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.63M 0.03%
34,939
-4,356
-11% -$181K
ARKK icon
528
ARK Innovation ETF
ARKK
$5.66B
$1.63M 0.03%
36,922
-29,668
-45% -$1.18M
TRMB icon
529
Trimble
TRMB
$13.2B
$1.62M 0.03%
30,695
+1,291
+4% +$63.1K
CCL icon
530
Carnival Corporation Ltd
CCL
$38.1B
$1.62M 0.03%
86,133
-22,928
-21% -$268K
STZ icon
531
Constellation Brands
STZ
$22.2B
$1.62M 0.03%
6,563
+27
+0.4% +$6.32K
VSS icon
532
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$1.61M 0.03%
14,610
-628
-4% -$69.2K
UTHR icon
533
United Therapeutics
UTHR
$25.8B
$1.61M 0.03%
7,286
+722
+11% +$160K
KRE icon
534
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$1.6M 0.03%
39,169
-2,068
-5% -$84.9K
SOFI icon
535
SoFi Technologies
SOFI
$21B
$1.59M 0.03%
190,825
+296
+0.2% +$1.93K
CAH icon
536
Cardinal Health
CAH
$53.9B
$1.59M 0.03%
16,785
-1
-0% -$84
PNC icon
537
PNC Financial Services
PNC
$99.7B
$1.58M 0.03%
12,526
-7,222
-37% -$883K
IVE icon
538
iShares S&P 500 Value ETF
IVE
$49B
$1.58M 0.03%
9,773
-1,449
-13% -$223K
AMP icon
539
Ameriprise Financial
AMP
$48.3B
$1.57M 0.03%
4,730
-367
-7% -$113K
IDV icon
540
iShares International Select Dividend ETF
IDV
$8.45B
$1.57M 0.03%
59,574
-6,950
-10% -$190K
WELL icon
541
Welltower
WELL
$169B
$1.57M 0.03%
19,385
-734
-4% -$56.5K
URTH icon
542
iShares MSCI World ETF
URTH
$7.99B
$1.57M 0.03%
12,578
-922
-7% -$111K
MPT
543
Medical Properties Trust
MPT
$2.77B
$1.56M 0.03%
168,316
-18,014
-10% -$152K
NBIX icon
544
Neurocrine Biosciences
NBIX
$16.8B
$1.55M 0.03%
16,483
+25
+0.2% +$2.44K
BND icon
545
Vanguard Total Bond Market
BND
$157B
$1.55M 0.03%
21,350
-1,644
-7% -$120K
CHI
546
Calamos Convertible Opportunities and Income Fund
CHI
$1.01B
$1.55M 0.03%
138,223
+25,600
+23% +$271K
AR icon
547
Antero Resources
AR
$11.1B
$1.54M 0.03%
67,027
-62,243
-48% -$1.38M
CGDV icon
548
Capital Group Dividend Value ETF
CGDV
$37.7B
$1.52M 0.03%
56,226
+8,151
+17% +$209K
TT icon
549
Trane Technologies
TT
$100B
$1.52M 0.03%
7,941
-496
-6% -$88K
OLLI icon
550
Ollie's Bargain Outlet
OLLI
$4.44B
$1.52M 0.03%
26,199
-1,627
-6% -$100K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.